A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 versus Placebo in Levodopa-induced Dyskinesia in Parkinson’s Disease A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Prelimin ...
A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 versus Placebo in Levodopa-induced Dyskinesia in Parkinson’s Disease A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Prelimin ...
Parkinson´s disease;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Product Code: NLX-112 INN or Proposed INN: BEFIRADOL